Prostacyclin and the fibrinolytic system in ischemic vascular disease.
D000328:Adult; D001161:Arteriosclerosis / Q000097:blood* / Q000188:drug therapy; D011464:Epoprostenol / Q000008:administration & dosage*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D010958:Plasminogen / Q000032:analysis; D011453:Prostaglandins / Q000008:administration & dosage*; D011928:Raynaud Disease / Q000097:blood* / Q000188:drug therapy; D000979:alpha-2-Antiplasmin / Q000032:analysis
D005338:Fibrin Fibrinogen Degradation Products; D011453:Prostaglandins; D000979:alpha-2-Antiplasmin; D005340:Fibrinogen; D010958:Plasminogen; D011464:Epoprostenol